These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18336210)

  • 1. "Spirit" of high throughput screening.
    Wesche H; Xiao SH; Young S
    Comb Chem High Throughput Screen; 2008 Mar; 11(3):174. PubMed ID: 18336210
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for content--the evolution of high throughput.
    Dove A
    Nat Biotechnol; 2003 Aug; 21(8):859-64. PubMed ID: 12894197
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for drug discovery: the leading question.
    Smith A
    Nature; 2002 Jul; 418(6896):453-9. PubMed ID: 12140563
    [No Abstract]   [Full Text] [Related]  

  • 4. Mainstreaming microfluidics: diffusing microfluidics technology in the marketplace.
    Braun D
    Pharmacogenomics; 2003 Jul; 4(4):375-8. PubMed ID: 12831316
    [No Abstract]   [Full Text] [Related]  

  • 5. [High throughput screening in the process of drug discovery].
    Ueki T
    Nihon Yakurigaku Zasshi; 2007 Apr; 129(4):276-80. PubMed ID: 17435340
    [No Abstract]   [Full Text] [Related]  

  • 6. From in vivo to in vitro/in silico ADME: progress and challenges.
    Van de Waterbeemd H
    Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):1-4. PubMed ID: 16922647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated assessment of preclinical data: shifting high attrition rates to earlier phase drug development.
    Korstanje C
    Curr Opin Investig Drugs; 2003 May; 4(5):519-21. PubMed ID: 12833643
    [No Abstract]   [Full Text] [Related]  

  • 8. Going, going, gone: from microscale to nanoscale analysis.
    van der Valk AM
    Drug Discov Today; 2003 Sep; 8(17):781-3. PubMed ID: 12946639
    [No Abstract]   [Full Text] [Related]  

  • 9. High throughput screening: early successes indicate a promising future.
    Fox S; Wang H; Sopchak L; Khoury R
    J Biomol Screen; 2001 Jun; 6(3):137-40. PubMed ID: 11689109
    [No Abstract]   [Full Text] [Related]  

  • 10. Discovery of a new drug--from target identification to ultra-high-throughput screening.
    Golz S; Hüser J
    Clin Lab; 2007; 53(1-2):77-9. PubMed ID: 17323829
    [No Abstract]   [Full Text] [Related]  

  • 11. Packaging challenges: the solution is just beyond the border.
    Merritt J
    Med Device Technol; 2003 Mar; 14(2):12-5. PubMed ID: 12698691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity-based screening techniques for enhancing lead discovery.
    Comess KM; Schurdak ME
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High throughput screening informatics.
    Ling XB
    Comb Chem High Throughput Screen; 2008 Mar; 11(3):249-57. PubMed ID: 18336217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-optical screening platforms: the next wave in label-free screening?
    Cooper MA
    Drug Discov Today; 2006 Dec; 11(23-24):1068-74. PubMed ID: 17129825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time molecular and cellular analysis: the new frontier of drug discovery.
    Taylor DL; Woo ES; Giuliano KA
    Curr Opin Biotechnol; 2001 Feb; 12(1):75-81. PubMed ID: 11167077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical drug discovery research and training at Vanderbilt.
    Lindsley CW; Weaver D; Jones C; Marnett L; Conn PJ
    ACS Chem Biol; 2007 Jan; 2(1):17-20. PubMed ID: 17243778
    [No Abstract]   [Full Text] [Related]  

  • 17. Structure-based virtual screening: an overview.
    Lyne PD
    Drug Discov Today; 2002 Oct; 7(20):1047-55. PubMed ID: 12546894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of high-content analysis for compound screening and target selection.
    Rausch O
    IDrugs; 2005 Jul; 8(7):573-7. PubMed ID: 15973566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High throughput assay technologies for ion channel drug discovery.
    Zheng W; Spencer RH; Kiss L
    Assay Drug Dev Technol; 2004 Oct; 2(5):543-52. PubMed ID: 15671652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of inhibitory drug interactions during drug development: genetic polymorphisms must be considered.
    Lee LS; Nafziger AN; Bertino JS
    Clin Pharmacol Ther; 2005 Jul; 78(1):1-6. PubMed ID: 16003286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.